Plus   Neg

Bausch Announces Approval Of VYZULTA In Brazil - Quick Facts

Bausch Health Companies Inc. (BHC), Bausch + Lomb, and Nicox announced VYZULTA, 0.024%, has received regulatory approval from the Brazilian Health Regulatory Agency. It is indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The approval of VYZULTA in Brazil marks its tenth regulatory approval.

VYZULTA, or latanoprostene bunod ophthalmic solution, is now approved in 10 markets, including Argentina, Brazil, Canada, Colombia, Hong Kong, Mexico, South Korea, Taiwan, Ukraine and the United States. Nicox generates revenue from VYZULTA in glaucoma, licensed exclusively worldwide to Bausch + Lomb.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Fast-food giant McDonald's said it will be raising hourly wages for more than 36,500 hardworking employees at McDonald's-owned restaurants by an average of 10 percent to make it among the industry-leading pay and benefits package. These increases, which have already begun, will be rolled out over the next several months. Biogen Inc. (BIIB) Friday said its XIRIUS study of cotoretigene toliparvovec failed to meet its primary endpoint in Phase 2/3 in patients with X-linked retinitis pigmentosa or XLRP. The company further noted that the study obtained positive trends in other pre-specified clinically relevant endpoints,... General Mills Inc. (GIS) agreed to buy Tyson Foods' (TSN) pet treats business for $1.2 billion in cash, the companies said in a statement on Friday. The transaction includes the Nudges, Top Chews and True Chews brands. General Mills will also acquire a manufacturing facility in Independence, Iowa.
Follow RTT